Latest Insider Transactions at Century Therapeutics, Inc. (IPSC)
This section provides a real-time view of insider transactions for Century Therapeutics, Inc. (IPSC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Century Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Century Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2023
|
Michael Craig Diem Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+16.41%
|
-
|
|
Aug 09
2022
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
364,800
-3.09%
|
-
|
|
Aug 09
2022
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
550,000
-4.45%
|
$7,150,000
$13.03 P/Share
|
|
Jan 31
2022
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
178,996
-1.43%
|
-
|
|
Dec 23
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
371,004
-2.87%
|
-
|
|
Jun 22
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+12.28%
|
$2,000,000
$20.0 P/Share
|
|
Jun 22
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
614,095
+50.0%
|
-
|
|
Jun 22
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
9,936,011
+43.48%
|
-
|
|
Jun 22
2021
|
Aktiengesellschaft Bayer > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
750,000
+5.59%
|
$15,000,000
$20.0 P/Share
|
|
Jun 22
2021
|
Aktiengesellschaft Bayer > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
11,925,838
+30.7%
|
-
|
|
Jun 22
2021
|
Fujifilm Cellular Dynamics, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,974,404
+36.36%
|
-
|
|
Jun 22
2021
|
Eli Casdin Director |
BUY
Open market or private purchase
|
Indirect |
750,000
+18.96%
|
$15,000,000
$20.0 P/Share
|
|
Jun 22
2021
|
Eli Casdin Director |
BUY
Conversion of derivative security
|
Indirect |
2,456,380
+50.0%
|
-
|